perindopril teva
teva pharma b.v. - perindoprilio tozilatas - plėvele dengtos tabletės - 10 mg; 2,5 mg; 5 mg - perindopril
prenessa
krka, d.d., novo mesto - tert-butilamino perindoprilis - burnoje disperguojamos tabletės - 8 mg; 4 mg - perindopril
prestarium
les laboratoires servier - perindoprilio argininas - plėvele dengtos tabletės - 10 mg; 2,5 mg; 5 mg - perindopril
quinapril-teva
teva pharma b.v. - kvinaprilis - plėvele dengtos tabletės - 20 mg; 10 mg; 40 mg - quinapril
vellofent
aziende chimiche riunite angelini francesco - a.c.r.a.f. s.p.a. - fentanilis - poliežuvinės tabletės - 533 µg; 400 µg; 267 µg; 133 µg; 67 µg; 800 µg - fentanyl
vidonorm
gedeon richter plc - tert-butilamino perindoprilis/amlodipinas - tabletės - 8 mg/10 mg; 8 mg/5 mg; 4 mg/5 mg; 4 mg/10 mg - perindopril and amlodipine
elidel
viatris healthcare limited - pimekrolimuzas - kremas - 10 mg/g - pimecrolimus
fosinopril actavis
teva b.v. - fosinoprilio natrio druska - tabletės - 10 mg; 5 mg; 20 mg - fosinopril
oloko
rivopharm ltd. - fosinoprilio natrio druska - tabletės - 20 mg - fosinopril
trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antinavikiniai vaistai - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.